RxDoctor Payments Data

Robert Richards

Psychiatry · Greenville, SCNPI 1598896144

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $132,876 of the $142,405 with a category attached, or 93.3%. Otsuka America Pharmaceutical, Inc. accounts for 69.4% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $38,943 and has fallen 99.6% since, to $164 in 2025. Among psychiatry clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$142,405in general payments, 2019–2025

Across 247 payments — averaging $576.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$99K
  • AbbVie$43K
  • Takeda Pharmaceuticals U.S.A., Inc.$188
  • Davol Inc.$164
  • Lundbeck LLC$155
  • Teva Pharmaceuticals USA, Inc.$131
  • plus $218 from 6 others

What the payments were for

  • Speaking & faculty fees$132,87693%
  • Travel & lodging$6,3244%
  • Food & beverage$3,1662%
  • Education$400%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$142,405 in reported general payments places this provider in the 95th percentile of 624 psychiatry providers in South Carolina.

See all psychiatry providers in South Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine14$150,676
VraylarCariprazine Hcl13$18,001
VyvanseLisdexamfetamine Dimesylate34$14,585
Aripiprazole78$10,975
Loreev XrLorazepam11$4,341
Clorazepate Dipotassium11$3,038
Lisdexamfetamine Dimesylate14$2,968
Vilazodone Hcl18$2,561
Bupropion XlBupropion Hcl84$2,311
Venlafaxine Hcl ErVenlafaxine Hcl108$2,096
Gabapentin80$2,061
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine39$1,777
Duloxetine Hcl47$1,550
Divalproex Sodium ErDivalproex Sodium27$1,497
Memantine Hcl71$1,325

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$131$150,67614 claims
AbbVieVraylar$42,786$18,00113 claims
Takeda Pharmaceuticals U.S.A., Inc.Vyvanse$188$14,58534 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 624 psychiatry providers in South Carolina.

Other psychiatry in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →